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Abstract We introduce a microfluidic device for chemical
manipulation and mechanical investigation of circulating
cells. The device consists of two crossing microfluidic chan-
nels separated by a porous membrane. A chemical compound
is flown through the upper Bstimulus channel^, which diffuses
through the membrane into the lower Bcell analysis channel^,
in which cells are mechanically deformed in two sequential
narrow constrictions, one before and one after crossing the
stimulus channel. Thus, this system permits to measure cell
deformability before and after chemical cues are delivered to
the cells within one single chip. The validity of the device was
tested with monocytic cells stimulated with an actin-
disrupting agent (Cytochalasin-D). Furthermore, as proof of
principle of the device application, the effect of an anti-
inflammatory drug (Pentoxifylline) was tested on monocytic
cells activated with Lipopolysaccharides and on monocytes
from patients affected by atherosclerosis. The results show
that the system can detect differences in cell mechanical de-
formation after chemical cues are delivered to the cells
through the porous membrane. Diffusion of Cytochalasin-D
resulted in a considerable decrease in entry time in the narrow
constriction and an evident increase in the velocity within the
constriction. Pentoxifylline showed to decrease the entry time
but not to affect the transit time within the constriction for
monocytic cells. Monocytes from patients affected by athero-
sclerosis were difficult to test in the device due to increased
adhesion to the walls of the microfluidic channel. Overall, this
analysis shows that the device has potential applications as a
cellular assay for analyzing cell-drug interaction.
Keywords Mechanical deformation . chemical stimulation .
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1 Introduction
Blood cell deformability can affect vascular flow and can play a
significant role in cardiovascular diseases, such as chronic in-
flammatory diseases. Drugs used for vascular complications can
change biophysical properties of blood cells, due to their effect
on cell membrane, cell cytoskeleton and cell fate, such as apo-
ptosis (Lam et al. 2007; Ruef et al. 2010; Rosenbluth et al. 2008;
Wuang et al. 2011; Dai et al. 2010). Therefore, it is of significant
importance to study mechano-biological changes of diseased
circulating cells in the development of a new treatment.
The analysis of mechanical effects of cell-drug interaction is
essential for biochemistry and clinical applications, for example in
drug screening and toxicity testing. Despite the fact that conven-
tional macroscopic assays for drug development are still widely
used, microfluidic technology has attracted increasing interest in
the past years (Nguyen et al. 2013; Abkarian et al. 2006; Dai et al.
2010; Adamo et al. 2012; Mao et al. 2012; Ma et al. 2009).
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Integrated microfluidic devices can be used to perform reproduc-
ible analyses on small sample volumes, at reduced reagent con-
sumption, and with precise system control. Furthermore,
microfluidics is being regarded as an excellent platform for cell-
based assays since it enables analysis at the single cell level in an
in vivo-like environment, allowing for controlled cell and biomol-
ecule manipulation and interrogation, while still offering the per-
spective to analyze many cells within a short time. In particular,
controlling diffusion of chemical agents in a microfluidic device
permits to realize a stable chemical gradient that can be main-
tained for prolonged periods of time, or create stable concentration
levels of chemicals relevant for cellular assays. At the same time,
microfluidic devices offer the ability to observe in real-time the
cellular responses to applied chemicals. Thus, microfluidic-based
cell platforms can be used to generate biomolecular gradients
mimicking biological signaling occurring in vivo, and to test
concentration-dependent cellular response to chemical treatments.
Recently, a number of cell-based microfluidic systems have
been described that have a perfusion cell culture chamber in
which medium flow is not only used to feed cultured cells
continuously, but also to provide additional functionalities, such
as generating gradients of drug concentrations. Liu et al. devel-
oped a microfluidic method for monitoring in real time the
effect of an anticancer drug on cancer glioma cells (Liu et al.
2010). Furthermore, to generate stable chemical gradients with-
out producing shear stress over cultured cells, gradient barriers
such as membranes (Abhyankar et al. 2006; Kim et al. 2009) or
hydrogels (Saadi et al. 2007; Cheng et al. 2007;Mosadegh et al.
2007) have been integrated in microfluidic devices. These sys-
tems allow establishing a controllable chemical gradient with-
out affecting the fluid flow in the cell area. Kim et al. (Kim et al.
2009) developed a device that generates a steep gradient inter-
face of small molecules over a cell culture. They established the
chemical gradient by separating the gradient channel and the
cell culture channel with a polyester membrane and measured
the uptake of the chemical by the cultured cells. Abhyankar et
al. (Abhyankar et al. 2006) created a stable chemical gradient
without requiring fluid flow by diffusion through a membrane
from a chemical source region. Saadi et al. (Saadi et al. 2007)
developed a microfluidic device for generating stable concen-
tration gradients based on a two-compartment diffusion system
consisting of two large parallel channels connected by horizon-
tal microgrooves filled with collagen gel. The device was val-
idated by observing neutrophil chemotaxis in a soluble
chemoattractant (IL-8) gradient. Cheng et al. (Cheng et al.
2007) used a hydrogel-based microfluidic device to monitor
cell migration and chemotactic response of suspension cells.
Another benefit of microfluidic devices is that it is possible
to accomplish sequential processes in a single device, such as
sample handling, controllable mixing and diffusion of
chemicals, detection and analysis. The design of the system
can then be integrated with additional features to achieve mul-
tiple measurements in a single experiment.
In this paper, we discuss the design, the fabrication and the
characterization of a new microfluidic device that integrates
two single-cell functions, namely mechanical and chemical
manipulation. The drug stimulation chip developed in this
study has the potential to be used for the analysis of cell-
drug interaction due to the ability to test the mechanical effects
of chemicals in a single chip. This device consists of two
crossing channels separated by a porous membrane (Fig. 1):
the chemical compound flows in the upper channel and can
diffuse through the membrane to the lower channel where the
cells flow and in which the mechanical cell analysis takes
place. This cell analysis channel consists of two sequential
constrictions, one before and one after a serpentine structure
at which the two channels cross and where the chemical stim-
ulation of the cells takes place. The constrictions were de-
signed to investigate cell stiffness in correlation to its influ-
ence on cell trafficking through the channels before and after
chemical stimulation. Hence, in one single device, the serpen-
tine enables cell retention for drug delivery to the cells through
the porous membrane connected to an upper stimuli channel,
and the constrictions enable mechanical characterization be-
fore and after the drug delivery.
In order to validate the device, the effect on mechanical
properties of circulating cells of Cytochalasin-D, an actin-
disrupting chemical, was investigated. Furthermore, the effect
of Pentoxifylline, an anti-inflammatory drug, both on LPS-
activated monocytic cells and on monocytes from patients
affected by atherosclerosis was testes as a demonstration of
the application of the device. Treatment with Cytochalasin-D
resulted in a considerable decrease in entry time in the con-
striction and an evident increase in the velocity within the
constriction. Application of Pentoxifylline to LPS-activated
cells resulted in a slight decrease of entry time but no relevant
change in the speed in the narrow channel was observed.
Analysis of monocytes from patients affected by atheroscle-
rosis resulted extremely difficult due to increased adhesion of
flowing cells to the walls of the microfluidic channel. Overall,
the results demonstrate the feasibility of the system for simul-
taneous chemical manipulation and analysis of cellular me-
chanical changes.
2 Materials and methods
2.1 Device principle
The constriction design permits the investigation of cell stiff-
ness, while chemical diffusion through a porous membrane
enables chemical manipulation.
Constricted microchannels have been used previously in
microfluidic analysis of cell mechanical properties. Since this
structure geometrically mimics the in vivo capillary-like mi-
croenvironment, it allows for mimicking the biorheological
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behavior of cells as they pass through narrow constrictions of
the blood capillaries. Constriction channels, which are smaller
than the diameters of tested cells, provide an effective method
to generate mechanical stimuli. Multiple parameters, such as
entry time, transit time, elongation and recovery time, in as-
sociation with cell deformability, can be quantified.
The integration of porous membranes into microfluidic de-
vices offers many opportunities, such as diffusion of chemicals
between two channels or chambers. The diffusion of chemicals
through the porous membrane integrated in our chip depends
on the difference in concentration between the upper stimulus
channel and the lower analysis channel. The diffusion D of the
chemical compound is defined by the Stokes-Einstein equation




where K is Boltzmann’s constant, T the temperature, η the fluid
viscosity, and R the molecule radius. By substituting the esti-








where ρ is the fluid density, N the Avogadro number andM the
molecular weight of the diffusing molecule. Then, the flux J
through the membrane reads







where n is the porosity of the membrane and ∇C is the concen-
tration gradient.
In our device the length of the serpentine channel is de-
signed to be much larger than the diffusion length, defined as
the distance that the compound travels by diffusion while
being transported by the fluid flow at the imposed flow rate
through the serpentine channel. This design of the serpentine
channel allows the compound to get into contact with the
flowing cells in the lower microfluidic channel for the desired
residence time.
The height of the microfluidic analysis channel and of the
stimuli channel was 20 μm. The constriction channel had a
width of 7.5 μm and a length of 250 μm. The serpentine
channel had a width of 150 μm and a length of 31 mm. The
stimuli channel had a width of 2.4 mm and a length of 7.5 mm.
The fluid flowwas driven by applying a hydrostatic pressure
drop over the device. The pressure drop was generated by the
difference in height of a liquid in reservoirs in the inlet and the
outlet. By carefully adjusting the liquid levels, the liquid flow
rate can be regulated. The flow rate was adjusted to obtain
sufficient incubation time of the cells with the drug while
flowing through the serpentine. The pressure drop is given by













whereQ is the flow rate andR is the hydraulic resistance, t is the
mean fluid residence time within the channel, μ is the dynamic
viscosity. L, w, h, A are the geometrical characteristics of the
channel (length, width, height and area respectively). The cell
residence time was measured also experimentally within the
microfluidic serpentine, by recording the cell trafficking
through the complete serpentine. In these preliminary studies,
the effect of deformation in the first constriction on cell me-
chanical properties was considered by observing the difference
in entry time and cell velocity between the first and second
constrictions.
Fig. 1 Left, Images of the microfluidic device consisting of three inlet
holes (i1, i2, i3), two narrow constrictions (a), the serpentine channel with
the upper stimuli channel (b) and the outlet hole (o). The magnified
images show (a) the two constrictions with a cell entering in the first
channel (red circle) and (b) the serpentine with the porous membrane
on top, with a flowing cell stimulated by the chemical compound
diffusing through the membrane from the upper stimulus channel. Scale
bar for magnified images A&B is 100 μm. Right, 3D exploded view of
the device displaying the three components of the device (the upper
stimulus channel, the porous membrane and the lower cell analysis
channel with two sequential constrictions)
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2.2 Design and fabrication
The device consisted of three components (Fig. 1): the upper
stimulus channel with inlets and outlet holes (Fig. 2, I), the cell
analysis channel (Fig. 2, II) and the porous membrane located
between these two channels (Fig. 2, III). The device was fab-
ricated from two layers of (poly)dimethylsiloxane (Sylgard
184, Dow Corning, The Netherlands), for the upper stimulus
channel (I) and for the lower cell analysis channel (II), and a
custom-made SU-8 membrane with through pores 3 μm in
diameter (III).
The fabrication process is shown in Fig. 2 as two phases,
namely the 1st Phase illustrating the fabrication of the three
layers (two PDMS layers and one SU-8 membrane layer) and
Fig. 2 Steps of the fabrication of the microfluidic device, divided in a 1st
Phase: Making the layers and a 2nd Phase: Assembling the layers. First,
for the fabrication (1st Phase), the stimulus (I) and the cell analysis (II)
layers were fabricated by pouring PDMS on the microstructures of the
master (I.a and II.a) and by curing the elastomer for 1 h at 110 °C (I.b and
II.b). The membrane layer (III) was fabricated by photolithography of an
SU-8 2010 film on a PDMS layer. The PDMS mixture was poured on a
silicon wafer (III.a) and was cured (III.b). SU-8 2010 was spun onto the
PDMS layer (III.c) and it was pre-baked (III.d) with a controlled
temperature ramp. Then, the layer was exposed by UV light through a
mask defining the porous structure (III.e), post-baked (III.f) and then
developed in SU-8 developer (III.g). For assembling the device (2nd
Phase), the PDMS cell analysis layer was activated in nitrogen plasma
(II.c) and immediately aligned and bonded to the SU-8 membrane layer
and baked overnight (II&III.a). The SU8-PDMS structure was then
peeled off from the PDMS sacrificial layer (II&III.b). Inlet and outlet
ports were cut in the stimulus PDMS layer (I.c). The stimulus layer was
then aligned to the SU-8 membrane and bonded by nitrogen surface
treatment (I.d) followed by curing overnight (I&II&III.a) to get the final
assembled device
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the 2nd Phase illustrating the assembly of the layers. Briefly,
the PDMS layers (I&II) were fabricated using prototyping and
multilayer soft lithography. The stimulus layer (I) and the cell
analysis layer (II) were generated from two transparency
masks made in plastic foil and chromium on glass, respective-
ly. The photoresist-based negative molds (SU-8, MicroChem,
Germany) were patterned on silicon wafers from the transpar-
ency masks by contact photolithography. Positive replicas
were fabricated by pouring a 10:1 mixture of PDMS on the
microstructures of the master of the stimuli channel and of the
cell analysis channel (Fig. 2, I.a and II.a) and by curing the
elastomer for 1 h at 110 °C (1st Phase: I.b and II.b).
The membrane layer (III) was fabricated in a unique and
custom way by photolithography of an SU-8 2010 film on a
PDMS layer used both as carrier and as sacrificial substrate. In
detail, the PDMS mixture was poured on a silicon wafer, was
allowed to evenly spread on the substrate on a flat surface for
30 min at room temperature (Fig. 2, 1st Phase: III.a) and sub-
sequently it was cured at 110 °C for 1 h (Fig. 2, 1st Phase:
III.b). SU-8 2010 was spun onto the PDMS layer at a spinning
frequency of 500 rpm for 10 s, followed by a cycle of
3000 rpm for 30 s (Fig. 2, III.c). This spincoating procedure
resulted in a 7-μm-thick SU-8 layer. After spinning, the SU-8
layer was pre-baked (Fig. 2, 1st Phase: III.d) with a controlled
temperature ramp (first 2 min at 50 °C followed by 10 min at
65 °C). Then, the layer was exposed by UV light (Near UV
Exposure System 350 Watt, ABM, USA) with an exposure
energy of 120 mJ/cm2 through a mask defining the porous
structure (Fig. 2, 1st Phase:III.e). Finally, the SU-8 layer was
post-baked for 3 min at 90 °C (Fig. 2, 1st Phase:III.f) and then
developed for 2 min in SU-8 developer (MrDev, Mircoresist,
Germany) to remove the uncrosslinked resist (Fig. 2, 1st
Phase:III.g).
In order to assembly the device, the layers were at-
tached to each other by following these sequential steps
(2nd Phase). The PDMS cell analysis layer was activat-
ed in nitrogen plasma (Fig. 2, 2nd Phase: II.c) and
immediately aligned and bonded to the SU-8 membrane
layer; the adhesion was consolidated by baking the
structure at 75 °C overnight (Fig. 2, 2nd Phase:
II&III.a). The SU8-PDMS structure was then peeled
off from the PDMS sacrificial layer (Fig. 2, 2nd
Phase: II&III.b). Lastly, the stimulus layer had to be
bonded to complete the device. Inlet and outlet ports
were punched in the stimulus PDMS layer (Fig. 2,
2nd Phase: I.c) using a biopsy needle (Harris,
The Netherlands). The stimulus layer was then treated
by nitrogen plasma (Fig. 2, 2nd Phase: I.d) and subse-
quently aligned and attached to the SU-8 membrane
followed by curing at 75 °C overnight (Fig. 2, 2nd
Phase: I&II&III.a). The final assembled device (Fig. 2,
2nd Phase: I&II&III.b) was connected by silicon tubing
to liquid reservoirs to generate the desired flow in the
channels driven by hydrostatic pressure difference. Prior
to cell analysis, the channel was coated with 1 % non-
adhesive Pluronic solution for 1 h and washed with
phosphate buffered saline for 40 min.
2.3 Cell culture and chemical stimulation
Human promyelocytic leukemia HL60 cells were used as amod-
el cell line for monocytes. The cells were obtained from the
European Collection of Cell Cultures (ECACC) and cultured in
RPMI 1640 medium (Invitrogen, The Netherlands) with
2 mM L-glutamine (Lonza, Belgium) and 10 % Fetal Bovine
Serum (Greiner, TheNetherlands). Cell cultures weremaintained
at a concentration between 1−9×105 cells/ml at 37 °C in a hu-
midified atmosphere containing 5 % CO2. Cell differentiation
towards monocytic lineage was stimulated by treatment with
0.4 mM Sodium Butyrate (Sigma, The Netherlands), for 4 days
at culturing conditions prior to experiment. Cell activation was
induced by incubation with 2 μg/ml Lipopolysaccharides (LPS,
Sigma, The Netherlands) for 15 min at 37 °C.
For the validation experiment, non-treated HL60 cells (NT)
were stimulated by diffusion of Cytochalasin-D (CytoD,
Sigma, The Netherlands) through the porous membrane from
the upper stimulus channel to the lower cell channel. For the
demonstration of the application of the device, both activated
cells (LPS) and monocytes from patients affected by athero-
sclerosis were stimulated by diffusion of Pentoxyfilline (PTX)
through the porous membrane.
2.4 Data analysis
An inverted microscope (Zeiss Observer Z1) equipped with a
high-speed camera (MotionScope M5, Idtvision) was used to
record cell trafficking in the microfluidic channel.
Cell entry time was defined as the time between the cell
getting across the entry of the constriction and the cell clearing
the entrance. Cell velocity was calculated by using the time
interval between the cell clearing the entry and the cell
reaching the end of the constriction. Cell entry time and ve-
locity in the channel were plotted against cell diameter. Cell
entry time and cell velocity in the channel were measured
from recorded videos, both for the first (before chemical stim-
uli, NT cell number=31, LPS cell number=19) and for the
second constrictions (after chemical stimuli, CytoD cell num-
ber=41, PTX cell number=15).
The relationships between trafficking parameters and cell
diameter were analysed with linear regression and the statisti-
cal significance of the differences in entry time and velocity in
the channel were tested by comparing the regression line
slopes and the intercepts (with values of p<0.05 considered
significant).
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3 Results
3.1 Experimental design
The concentration of the chemical in the upper chamber was
calculated based on Eq. 3, in order to reach in the lower cell
analysis channel a concentration of the compounds used pre-
viously in literature (Ruef et al. 2010; Du et al. 2011) within
the first minute of experimentation. For Cytochalasin-D, a
concentration of 5 μg/ml was used and for PTX a concentra-
tion of 1 mg/ml was chosen.
Furthermore, the flow rate in the cell analysis channel gen-
erated by the hydrostatic pressure drop was calculated both
theoretically by Eq. 4 as well as determined experimentally.
For the experiment with Cytochalasin-D a difference in height
of 25 mm corresponds to a cell residence time of 10 min in the
serpentine (corresponding to a flow rate of around 10 nl/min).
For the experiment with PTX a height difference of 50 mm
was used in order to stimulate the cells for 5 min in the ser-
pentine (around 19 nl/min).
In preliminary experiments, while flowing only the buffer
in the upper stimulus channel, we observed that cells recov-
ered completely in the serpentine channel from the deforma-
tion in the first constriction, and that, upon complete cell re-
covery, entry time and cell velocity in the second constriction
were not affected by cell transit in the first constriction at any
analyzed flow rates.
3.2 Validation of the device
CytoD, a known actin-disrupting agent, was used to demon-
strate the working principle of the device. The HL60 cell
solution was added in the lower microfluidic channel while
the CytoD solution was added in the upper stimulus channel.
Figures 3 and 4 show images captured from videos of
HL60 cells flowing in the first and second constrictions, re-
spectively. A difference in trafficking behavior before and
after CytoD stimulation can be clearly appreciated from the
timing indicated in the images. The entry time (Fig. 5) and
speed or trafficking velocity in the channel (Fig. 6) were then
calculated as a function of cell diameter. Although the spread
in the data is considerable, Fig. 5 clearly shows that the entry
time increased with cell diameter for non-treated HL60 cells,
while there was no clear diameter dependence for CytoD stim-
ulated cells. Most importantly, there was a strong decrease in
the time required to enter in the confined channel after stimu-
lation of the cells by CytoD. Although the spread of the data is
relatively high, as evidenced by the low R2 value, the differ-
ences between the slopes are significant.
The change in cell trafficking velocity in the constriction
due to the CytoD treatment was less evident than for the entry
time, as can be seen in Fig. 6. The behavior of non-treated
cells depended on cell diameter, with a decrease in speed
within the channel as cell diameter increased. The data for
CytoD stimulated cells showed too much variation to recog-
nize a clear trend. The spread of data was high and the linear
fitting was characterized by an extremely low R2 value. This
resulted in a contradictory apparent increasing trend in the cell
velocity as the cell diameter increased. Nevertheless, differ-
ence in cell speed in the constricted channel between the first
and the second constriction was observed: cells in the second
constriction, after treatment with CytoD in the serpentine sec-
tion with the porous membrane, had a higher trafficking ve-
locity. The differences between the slopes are significant.
Although both the entry time and the transit time are governed
Fig. 3 Images captured from the video taken of a HL60 cell flowing in the first constriction (before Cytochalasin-D stimulation). The entry time (interval
B-D) is around 10 s (from 24.975 to 34.025 s). The trafficking time (interval D-F) is 0.83 s
31 Page 6 of 11 Biomed Microdevices (2016) 18: 31
by cell mechanical stiffness, the two quantities were measured
independently and they were not derivable from each other.
The correlation between these two parameters is illustrated in
Fig. 7. There is a clear distinction between the measured pa-
rameters in the first constriction (not treated cells) and in the
second constriction (CytoD-treated cells).
This simple demonstration opens the door for future appli-
cations where clinical drugs used on circulating cells could be
tested to determine the effect on cell mechanical properties.
3.3 Demonstration of the application
Pentoxifylline (PTX), a drug used in inflammatory diseases,
was used to demonstrate the working principle of the system
by investigating the effect of this drug on LPS-activated
monocytic cells and on monocytes from patients affected by
atherosclerosis. Cells were flown through the lower
microfluidic channel while the PTX solution was added in
the upper stimulus channel.
Again, the entry time (Fig. 8) and the cell trafficking speed
within the constriction (Fig. 9) were determined as a function
of cell diameter. There was a clear dependence of the entry
time on cell diameter both for LPS activated cells and for
activated cells stimulated with PTX. The apparent decrease
in entry time after treatment was minor both at small and at
large cell diameter. Nevertheless, the differences between the
slopes are significant.
The trafficking velocity (Fig. 9) tended to decrease for
larger cells, for both cell groups, but the variation in the data
Fig. 4 Images captured from the video of an HL60 cell flowing in the second constriction (after Cytochalasin-D stimulation through the porous
membrane). The entry time (interval B-D) is around 0,11 s (from 4010 to 4.125 s). The trafficking time (interval D-F) is 0.55 s
Fig. 5 Entry time of HL 60 cells in the first constriction (before CytoD
stimulation, green circles) and in the second constriction (after CytoD
stimulation through the porous membrane, blue squares). The entry
time is plotted as a function of cell diameter. There is a clear
dependency on cell diameter for non-treated cells, while this
dependency is not present for CytoD-treated cells. Most importantly,
the entry time is substantially shorter after CytoD stimulation. The data
were fitted by a linear regression line (for the first constriction R2 = 0.34
and for the second constriction R2 = 0.02)
Fig. 6 HL60 cell velocity in the first constriction (before CytoD
stimulation, green circles) and in the second constriction (after CytoD
stimulation through the porous membrane, blue squares). The velocity
is plotted as a function of cell diameter. The trafficking velocity is,
overall, higher after treatment with CytoD through the porous
membrane. The data were fitted by a linear regression line (for the first
constriction R2 = 0.13 and for the second constriction R2 = 0.17)
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was too large, as also evidenced by the low R2 value, to draw
solid conclusions. Contrary to the CytoD experiment, there
was no difference in trafficking velocity in the constriction
channel between the two experimental groups. The differ-
ences between the slopes and between the intercepts were
not significant. Compared to the analysis with CytoD, the
differences caused by the drug treatment were not consider-
able in this case. This might be due to biological reasons, such
as the effect of the occasional adhesion of activated cells to the
channel wall, or to technical reasons, such as the incapability
of the device to detect differences in mechanical properties for
these cells and treatment.
The correlation between entry time and trafficking velocity
in the first and second constrictions is illustrated in Fig. 10.
There is no clear distinction between these parameters mea-
sured in the two constrictions.
The atherosclerotic patients’ cells tended to adhere to the
walls of the channels and the pseudopods projected by dis-
eased cells where often anchored to the wall of the channel
(Fig. 11). Furthermore, since monocytes from atherosclerotic
patients tend to form clusters due to increased adhesive prop-
erties of cell membrane, it was difficult to investigate the traf-
ficking behavior at single cell level. Thus, cell adhesion inter-
fered with the analysis of cell stiffness since it would influence
the entry time and the speed in the channel.
4 Discussion and conclusion
Most cellular processes, including those related to diseases,
are influenced by both mechanical and biochemical cues and
result in changes of the cytoskeletal and mechanical properties
Fig. 7 Correlation between cell entry time and cell velocity in the
constriction channels. There is a strong distinction between the cells in
the first constriction (before the porous membrane, NT HL60, green
circles) and the cells in the second constriction (after the porous
membrane CytoD treated HL60, blue squares)
Fig. 8 Entry time in the first constriction (LPS-treated HL60 cells before
PTX stimulation, red circles) and in the second constriction (LPS-treated
HL60 cells after PTX stimulation through the porous membrane, blue
squares). The entry time is plotted as a function of cell diameter. It
appears that there is a dependency on cell diameter for both
experimental groups, with an increase in entry time for larger cells. The
entry time for PTX-treated cells appears slightly smaller than for cells that
are only LPS-activated. The data were fitted by a linear regression line
(for the first constriction R2 = 0.76 and for the second constriction
R2 = 0.60)
Fig. 9 Cell trafficking velocity in the first constriction (LPS-treated
HL60 cells before PTX stimulation, red circles) and in the second
constriction (LPS-treated HL60 cells after PTX stimulation through the
porous membrane, blue squares). The velocity is plotted as a function of
cell diameter. It appears that there is no clear difference in trafficking
velocity between the experimental groups. The data were fitted by a
linear regression line (for the first constriction R2 = 0.11 and for the
second constriction R2 = 0.05)
Fig. 10 Correlation between HL60 cell entry time and cell velocity in the
constriction channels. There is no clear distinction between the cells in the
first constriction (LPS-activated only, red circle) and the cells in the
second constriction (LPS-activated and PTX-treated, blue squares)
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of cells. Thus, in the development and testing of cellular as-
says and disease treatments, it is important to control and
manipulate the chemo-mechanical cellular micro-
environment and to investigate the resulting cellular response.
In this paper, we have introduced and characterized a
microfluidic device that permits the investigation of cellular
mechanical response to biochemical stimuli at single cell level
in a physiologically relevant microenvironment. The key ele-
ment of the device is a porous membrane that separates a
stimulation channel (containing the biochemical agent) and a
cell testing channel (through which cells are flown), and
through which the agent can diffuse to reach the cells.
Microfluidic systems offer a number of opportunities in the
development of drug assays. Several microfluidic systems
have been proposed in which membranes or gel layers are
used as interfaces through which chemicals can diffuse to
the cells (Saadi et al. 2007; Abhyankar et al. 2006; Kim
et al. 2009; Cheng et al. 2007). The microfluidic system pro-
posed in this study has the following advantages. First, it
requires smaller volumes of stimulating agent compared to
conventional chemical assays. The chemical is placed in the
stimulus channel of the microfluidic device (with a volume of
around 2μl) and it is allowed to diffuse through the membrane
into the lower channel. Furthermore, the diffusion from the
upper chamber through a membrane permits a stable chemical
transfer without generating fluid shear forces and affecting the
flow in the lower analysis chamber.
The fabrication of the device is rather straightforward and
reproducible. The device design and the system parameters
can be changed to adapt the device to different cellular assays
and to increase the sensitivity of the device. Both the stimuli
and the cell analysis channels can be modified on the basis of
cell type and drug used. For instance, the porosity or the pore
size of the membrane could be changed according to the
choice of chemical compound and to the desired diffusion
rate. The design of the cell microfluidic channel could also
be adapted according to the drug used in the assay. For in-
stance, the length of the serpentine channel could be increased
if the drug requires a longer time of efficacy. In our validation
study we observed a clear distinction in entry time and traf-
ficking velocity between non-treated HL60 cells (first con-
striction) and CytoD-treated cells (second constriction). This
shift in trafficking behavior was not as considerable for LPS-
activated cells treated with PTX. Since this result might be due
to low sensitivity of the device to smaller changes in cell
mechanical properties, the design can be adapted (e.g. by de-
creasing constriction width) to improve the sensitivity.
On the other hand, the device is not applicable to all circu-
lating cell types and cellular pathologies. Despite the advan-
tages of this technique, cell deformability is associated with
cell adhesion between cell membrane and the wall of the
channel. Monocytic cells treated with LPS become stickier
than non-activated cells. Thus, in the analysis of activated
cells, even with the non-adhesive coating pre-treatment of
the device, it appeared that the cells tended to stick to the wall
or to the floor of the microfluidic channel due to increased
adhesive properties of activated cells. For the analysis of acti-
vated HL60 cells, the flow rate was increased to avoid cell
adhesion on the floor of the serpentine channel. However, this
resulted in a decreased sensitivity of the device since the de-
pendency of entry time on cell treatment is enhanced at low
pressure differences. Similar behavior was observed for the
monocytes from atherosclerotic patients where the cells
tended to adhere the pseudopods to the wall of the
microfluidic channel. For this reason, the specific design of
this setup does not seem to be appropriate for analyses of
diseased cells with strong adhesive properties.
Different challenges were encountered in the choice and in
the incorporation of the porous membrane in the microfluidic
device. The membrane was required to have an array of pores
Fig. 11 Images captured from a video of a monocyte from an atherosclerotic patient trafficking into a constriction channel. It appears that, while exiting
the constriction, the monocyte remained anchored at the channel wall by the projected pseudopods (indicated with red arrows)
Biomed Microdevices (2016) 18: 31 Page 9 of 11 31
smaller than 5 μm to avoid cell migration towards the upper
stimulus channel but at the same time it needed to be fully
transparent over the constriction region to avoid the influence
of microscopic pores on the observation of cells in the con-
strictions. Thus, the membrane was custom made as a free-
standing SU-8 thin film over a substrate of PDMS as sacrifi-
cial layer. The fabrication of the membrane in a clean room
has the advantage that any feature can be tailor-made. In fact,
photolithography permits straightforward fabrication of mi-
crometer structures according to a preferred design with spe-
cific properties and thicknesses. The sealing of membranes in
microfluidic devices is a common problem. The incorporation
of the membrane was performed at elevated temperature by
reaction of the amino groups on the PDMS channel surface,
generated by exposure to pure nitrogen plasma, with the ep-
oxy group of the SU8 membrane surface.
The results shown are comparable with previous studies on
monocytic cells trafficking through narrow channels after
treatment with actin-disrupted agents (Gabriele et al. 2009;
Preira et al. 2013). Previous studies on Pentoxifylline showed
that this drug reduces pro-inflammatory response and de-
creases the amount of adhesion proteins, such as ICAM-1, in
monocytes (Neuner et al. 1997; Souness et al. 1996). PTXwas
also shown to have a mechanical effect on blood circulating
cells by a significant increase of the deformability of activated
granulocytes after 10 min of treatment with a 0.2 mg/ml PTX
solution (Ruef et al. 2010). Rosenbluth et al., proposed a
microfluidic-based flow cytometer to measure the transit time
of HL60 cells stimulated with Cytochalasin D and
Pentoxifylline. They observed that median transit time was
reduced from 0.63 s to 0.23 s for 1 h exposure of 2 μM of
CytoD solution and to 0.37 s for 3 h exposure of 1 mM PTX
solution (Rosenbluth et al. 2008).
In our study the change in mechanical properties of LPS-
activated monocytic cells after exposure to PTX was not sig-
nificant. There was a decrease in entry time after stimulation
with PTX but no difference was observed in the trafficking
velocity within the channel. This could be caused by biological
and/or technical reasons. In fact, it can be due to the short
residence time in the stimulus region (just 5 min, in contrast
to 3 h in Rosenbluth et al.). Furthermore, the measured entry
and trafficking time can be affected by the occasional adhesion
of activated cells to the wall or to the floor of the channel, as
previously described. On the other hand, the increase in the
flow rate used in this study could decrease sensitivity of the
device, as previously described, or the setup is not sensitive
enough to discriminate small differences in mechanical proper-
ties. Thus, further investigation is necessary to investigate the
sensitivity of the system by varying the driving pressure and by
considering different cell types and cellular modifications.
Despite the limitations, the preliminary characterization of
our device showed that it has potential applications for various
cellular assays investigating the interaction between
biochemical and mechanical cues. The device might be ad-
justed to the use for different applications. For instance, it
might be possible to investigate the in vivo-like cellular re-
sponse to molecule release in signaling processes by incorpo-
rating the secreted factors in the in vitro setup. This might then
lead to an enhanced understanding of the biophysical aspects
of biological processes, including diseases, and to assess the
effect of new treatments on diseased cells.
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